Connect with us


What I Learned Studying Real Vampires

A scene from “Interview with the Vampire” featuring Christian Slater and Brad Pitt. (Credit: Warner Bros./Youtube)

[Editor’s note: One of the most popular articles on our site is a piece by Georgia Institute of Technology researcher John Edgar Browning about his work with the real vampire community, published in March 2015. In it, Browning discusses what a real vampire is, how they live their lives, and what researchers are hoping to learn about them. Here, he expands on the difficulties of finding and studying this enigmatic group of people, as well as the lessons he’s learned in the process.]

With Christopher Rice’s tantalizing tweet about the new Vampire Lestat television treatment and news of Dacre Stoker and J.D. Barker’s Dracula prequel, Dracul, due out from Putnam in October, the topic of vampires again looms nigh for lovers of fiction and the supernatural. What happens, though, when the borders between fact and fiction fade into gray uncertainty?

For real vampires (or human vampires, as they are otherwise called), this is the reality they live with every day. What follows is not the full scope of their story. It’s not even a little. But it’s enough, I hope, to offer insight and invite curiosity. And perhaps, from some of us, even to spur self-reflection.

Vampire fiction aside, there are in this world people who actually do drink blood—from humans and animals alike—or drain from others what they call psychic energy. It’s a ritual performed not out of pleasure, but need, and it’s normally done with the utmost care for their donor’s safety and comfort. This need, according to them, arises from the lack of natural energies their bodies produce. Fittingly enough, they’ve adopted the word “vampire” to self-describe their unusual predilection, one which they claim begins to surface just after puberty.

The Vampire Interviewer

I know this because I’ve interviewed a number of real vampires face to face, during the course of my research as a graduate student, much like Christian Slater’s character in Interview with the Vampire. It’s not at all as glamorous as it sounds though, nor as easy. Real vampires aren’t particularly looking to be found, and if the comments section of articles on the topic is any measure, can we really blame them?

It all started for me about nine years ago, shortly before I transferred from a doctoral program in English in Southern Louisiana to one in American Studies in Western New York. It was at the height of what some of us vampire scholars were calling at the time the “vampire renaissance,” and on October 26, 2009 I inscribed in my field journal a passage that resonates with me still today, both for its foretaste as well as, or perhaps especially because of, its naiveté:

Baton Rouge.When attended Wicked New Orleans [on Decatur St. in New Orleans] on the 17th [of October], things went extraordinarily well. Shop owner was happy to oblige me in every respect and went out of his way to volunteer information. In the initial five minutes of my speaking with him, he gestured towards the other end of the store to a lady in her 40s-50s inspecting some clothing. ‘I think she’s a vampire,’ he said, ‘and I believe that’s her son with her.’ At this point I was mildly embarrassed, as I knew he expected me to go and confront her right then and there. I had not prepared for my ‘first time’ to happen this way. Nevertheless, I walked over to the woman and intruded with a polite but simple, ‘Pardon me.’ With a look of complete surprise, irritation, and curiosity, she turned to me, looked me in the eyes, and said nothing. So, I continued by introducing myself and my reason for being in the store. Then finally I said to her, which I must admit was incredibly awkward, ‘Do you know any [vampires]?’ I grinned, embarrassingly, to which she returned a grin to reveal that two of her most prominent teeth had been filed down to a pair of incisors. Her response, ‘Yes, I might know a few.’ I quickly began asking her a few questions, to make friendly conversation, but about what, to this day, I haven’t the faintest recollection. I then proceeded to give her my contact info, and politely asked if I might continue to speak with her at another time. While I did not ask for her own contact info—as I felt this would be too intrusive—I did ask for her name. To my complete surprise, she stated, simply, ‘Jennifer.’

“I never saw or heard from ‘Jennifer’ again.”

Jennifer was my first vampire. And at the time, I was sure she would be my last.

How very mistaken I was.

After I penned the above passage, mere days would pass before another similar experience propelled me to record in my notes again, this time my prose hardly masking my exhilaration:

“At night along the Bonnet Carré Spillway, a narrow stretch of I-10 bordering Lake Pontchartrain’s western shore, can be seen from afar in all its Gothic splendor the steel girdles and gaseous plumes that are the Shell Norco refinery, a structure betraying its solitary life in the dark expanse through only a few points of orange light here and there. Theirs—the play of steel, gas, and faint orange light—has become by now a familiar sight to me in the hours just after midnight as I leave behind New Orleans and the French Quarter, a ritual I have repeated nearly every week for two months. The feeling is almost always the same: The silence along this stretch of interstate is deafening after the trumpeting frenzy of Bourbon Street; my clothes smell of liquor, cigarettes, and fine cuisines; and everything around me has fallen into a dead calm. But this night in late October is different. Tonight, after months of searching, I met and spoke at length with five vampires living in New Orleans, members of a community in which I am an outsider.

This fateful encounter took place at Ye Olde Original Dungeon (or, simply, “The Dungeon”), a nightclub located on Toulouse Street in the French Quarter. As I sat at the bar drinking a whiskey sour and jotting down field notes, the bartender there (with whom I had already talked about the study I was conducting) shouted into my ear over a KoЯn song blaring overhead that I should go talk to “those people,” as she passed a sideward glance at some folks who had just walked in. I stood and thanked her, hurriedly finished off my drink for courage, then proceeded with my leather satchel over to two young gentlemen dressed all in black and standing against a wall. The first of these gentlemen, sporting a long dark ponytail, looked to be in his mid-30s, and the second, crowned with short spiky dirty-blond hair, looked to be in his early-20s. After introducing myself to the latter and explaining (loudly) that I was attempting to assess the number of, and most prominent features and practices by which, people living in New Orleans self-identify as vampire, I asked, simply, “Do you know any [vampires]?” To this he mocking grinned and replied, “Are you kidding?” And to my surprise (and relief), a pair of fangs extended prominently from behind the young man’s handsome smile.”

By early December, I would meet almost another two-dozen vampires in New Orleans, and each of them, beginning with Jennifer, taught me a valuable lesson about hiding in plain sight.

Blending In

Indeed, human vampires don’t simply live among us, I would find — they are us, in almost every detail. They are our teachers, our shop clerks, our bartenders, our antique dealers, our IT people, our friends, and for some even, our family and loved ones. Some of us work with vampires every day, or pass them on the street without ever knowing it. But, to understand real vampires, how they think and how they act, we must understand our own reactions to them.

In its dark corridors and gothic atmosphere, the Dungeon afforded the vampires that October night nine years ago relative safety, but what about outside its doors? In time, I would come to see these and other real vampires belittled by outsiders, called freaks or mentally ill. One vampire would even confide in me that she feared losing custody of her daughter if her estranged ex-husband were to learn of her “peculiarity.” Although my research carried with it an important responsibility, I scarcely knew it yet that night at The Dungeon.

I went into the study expecting nutcases and dreamers, Lestat wannabes and vampire fiction bookworms—but what I found were just people, sane people who by and large avoided the stereotypes we associate with vampirism (save for the first-rate prosthetic fangs some occasionally wore). It was I who’d been the fool, not them.

Lessons Learned

So, I changed course, and modified accordingly my prospective goals, becoming in the process more aware of my place among the people I was shadowing. As I did so something rather unexpected happened: The relationship between myself and the study participants progressed from being an auxiliary feature of my study to a more central one. At the monthly group meetings of New Orleans’ vampire elders I began to move from the periphery of the space we inhabited closer and closer to the inner circle, at first by their accord, then my own. In essence, I was becoming, they would later tell me, more and more just like one of the group, a sentiment I came to feel myself. In fact, their trust became a vital component of my research, as I would never have been able to collect my data without the close relationship I worked to foster. This relationship was hard earned, however, from a community only recently shaken by a breach of trust from a mainstream news service.

In the wake of the Twilight craze during the late 2000s, an ABC News 20/20 special report on New Orleans’s vampire community aired on November 27, 2009, just days after New Moon’s record-breaking opening weekend. To the local and greater vampire community, the piece was not exactly an accurate depiction of how they lived. It also didn’t reflect the broadcast ABC led the New Orleans vampire community to believe would air, one which would have included a demonstration of safe feeding practices and wound care, as well as any mention of their local charity work with the homeless. Thus, much of my “mission,” as I would later explain in interviews with the BBC and Washington Post, became simply to rectify this injustice by documenting, for myself, the behaviors and practices the 20/20 broadcast left out.

The Real Real Vampires

Using data gathered over five years of work in New Orleans and Buffalo, New York, I hoped to offer geographically-specific behavioral and socio-cultural insights to the participants, ultimately getting at what made the vampires at one site different from another site. I felt that geography could offer the most salient information about the intricacies of the real vampire identity. In the end, the lives of real vampires in different locations became a focus for my research.

The body of work dealing with real vampirism has been steadily growing since the early 1980s, especially in the last 9 years (the work of Joseph Laycock, DJ Williams, and Mark Benecke are prominent examples), but no study had attempted to explore this identity at a local level to ascertain whether geography and local culture played a role. What my findings eventually showed was that vampire self-identification in New Orleans offered a sharp contrast to how real vampires shaped their identity in Buffalo. In particular, local cultural norms seemed to be important — one doesn’t easily walk the streets of Buffalo sporting fangs as they would in New Orleans. Even more striking was the prominence of local group affiliation in New Orleans, where many vampires had organized into “houses” complete with a hierarchical system of elders and members. By comparison, Buffalo, a city seemingly without a centralized (or focalizing) neighborhood like the French Quarter, seemed to cater more to independence and individuality.

As I endeavored to truly understand (without further sensationalizing), this enigmatic community, I found what the real vampire identity ultimately achieves is a measure of self-empowerment. It’s something I’ve termed “defiant culture,” and it manifests itself in other marginalized communities the world over. Real vampirism is a way for people who might not fit into normal societal boxes to construct an identity and face a world that frequently shuns more than it embraces. While my research has worked to shed light on how deviant communities develop within repressive systems, it has also awakened one of its most familiar adversaries—people who marginalize whatever is outside their own experience. To outsiders, real vampires’ consumption of human blood or energy is not their greatest crime, but that they are a proud, living critique of normalcy is.

In the glamorous world of Hollywood, as indeed in real life, we fear dark places; we fear the unknown. But for these real vampires, there is safety in the shadows, in anonymity. Perhaps their supposedly grim nature is simply a reflection of our own darkness.

Continue Reading
Click to comment


We've Been Putting A Potentially Dangerous, Drug-resistant Yeast in Food for Centuries

A block of fresh yeast. (Credit: avs/Shutterstock)

You say to-MAY-to, I say to-MAH-to. You say po-TAY-to, I say po-TAH-to. You say Candida krusei, I say Pichia kudriavzevii — and that should make you a little nervous.

OK, so that last bit needs explaining. C. krusei is a drug-resistant yeast species that’s responsible for thousands of potentially fatal infections in the United States every year. P. kudriavzevii is a yeast species that’s been widely used for centuries in the food industry and is playing a larger role in the production of bioethanol and other chemicals.

C. krusei and P. kudriavzevii, two very different names, playing two very different roles … uhh, yeeeaaah, scientists have confirmed they’re the same species.

Indeed, we’ve been given the ole’ Jekyll-and-Hyde treatment, which means we’ve been using a drug-resistant strain of yeast, capable of infecting human beings, on an industrial scale for centuries. This little truth bomb comes courtesy of a team of researchers led by Alexander Douglass at the University College Dublin in Ireland.

A Yeast by Many Names

Yeast of the Candida species cause roughly 46,000 fungal infections in the U.S. every year, with a 30 percent mortality rate — the ebola virus hovers around 50 percent, by comparison. Candida yeasts actually reside in the intestines and can be found on the skin and mucous membranes. The trouble starts when these yeasts begin to multiply at far higher rates than normal, especially if they enter the bloodstream. Candida infections pose a particular threat to people with weakened immune systems.

The most notorious among the Candida gang of yeasts is C. albicans, which is the culprit behind more than half the annual Candida infections in the U.S. C. krusei, the yeast featured in this study, is only responsible for about 2 percent of infections. Still, you wouldn’t put C. krusei at the top of your ingredients list for your next meal.

But that’s exactly what we’ve been doing by using P. kudriavzevii around the world in fermented beverages, milk and biofuels.

Taxonomists Knew It

Yeast taxonomists back in 1980 proposed that C. krusei and P. kudriavzevii were the same species, but the theory was difficult to prove and the information didn’t trickle out to other scientists. And for decades, the yeast’s dual identity split the research community into two fronts, says Ken Wolfe, a UCD geneticist and co-author on the study.

“There are basically two separate communities of scientists working on this organism, publishing papers about it but calling it different names, which led to very poor communication and ignorance about each other’s work,” Ken Wolfe, a UCD geneticist and co-author on the study wrote in an email to Discover. “The medical people called it C. krusei, and the food/biotech people called it P. kudriavzevii.”

Because of the split, research comparing the genetic similarities of P. kudriavzevii and C. krusei was lacking. There had never been an analysis comparing the environmental and clinical strains of these two (well, one) yeast species.

So, Douglass and his team sequenced the genomes of 30 different strains of both yeast species. They found the strains share genomes that are 99.6 percent identical in DNA sequence. Researchers say that’s pretty conclusive evidence that they are the same. Douglass and his team published their findings Thursday in the journal PLOS Pathogens. Wolfe believes scientists would have arrived at this conclusion far sooner had the wider scientific community been privy to what the taxonomists already knew.

Now What?

How concerned is Wolfe about all of this? He’s at about a 3 on a scale of 1-10.

“This yeast only causes infections in immunocompromised people, such as organ transplant recipients or an AIDS patient,” says Wolfe. “People with healthy immune systems need not be concerned.”

You’ll find P. kudriavzevii in some craft beers, sourdough breads and pickled vegetables. Therefore, Wolfe would advise people with weak immune systems to avoid craft beer and pickles. The yeast poses a particular problem for organ transplant recipients because they are treated continuously with a drug known as fluconazole to prevent fungal infections.

“If these patients do get a fungal infection, it tends to be with a fluconazole-resistant species such as P. kudriavzevii. So for these patients, eating foods that contain P. kudriavzevii seems inadvisable,” says Wolfe.

The Centers for Disease Control and Prevention considers Candida fungal infections a growing threat, given that they are resistant to the fluconazole antifungal treatment. The C.D.C. considers anotherr strain in particular, C. auris, an emerging global threat. It’s causing infections and hospitalizations around the world, and is resistant to multiple forms of treatment.

Douglass says their research is a starting point, and should serve as a resource for ongoing investigations. It’s an earnest invitation for more researchers to examine these yeast strains a little closer, and perhaps rethink how we use them in future applications.

“I think it would be appropriate for regulators to make spot-checks on the food products, particularly to check that the P. kudriazeii strains they contain are not resistant to other drugs as well as fluconazole,” says Wolfe. “We found that some environmental strains of P. kudriazeii were relatively resistant to other drugs too.”

Continue Reading


The Curious Case of Acrylamide: California’s Prop. 65 Explained

(Credit: M. Unal Ozmen/Shutterstock)

Most of us think of coffee as a morning essential, not a cancer-causing hazard. So the nation got a jolt after a California judge made a final ruling in May that Starbucks and other coffee sellers must inform customers about carcinogenic chemicals in their brews.

The ruling stemmed from a court case invoking Proposition 65, a state law that requires warnings if products or places contain certain types of hazardous chemicals. But the implications reach far beyond the Golden State. California has the sixth-largest economy in the world, so manufacturers of consumer goods worldwide try to abide by Prop. 65 regulations.

Here’s a primer on how hazardous chemicals get listed and regulated, the ongoing coffee case — yes, it’s still not over — and what might be labeled or litigated next.

Why will there be signs next to Starbucks registers warning that coffee contains chemicals that cause cancer and birth defects?

In late March, a Los Angeles Superior Court judge ruled that cups of coffee sold to consumers would fall under the Safe Drinking Water and Toxic Enforcement Act — Prop. 65 — which was passed by a ballot vote of California residents in 1986. The judge made a final ruling May 7.

The law applies because roasted coffee beans — and beverages brewed from them — contain acrylamide, which is on Prop. 65’s state-regulated list of chemicals “known” to cause cancer, birth defects or reproductive harm. If a product contains any of the list’s approximately 900 chemicals, it must be labeled to warn consumers, or the chemical must be removed or reduced to levels that Prop. 65 regulators consider safe.

In April 2010, an organization called the Council for Education and Research on Toxics (CERT), which is located at the same address as the Long Beach law firm that represented it and that specializes in litigating such cases, sued about 160 companies, including Starbucks Corp. and the convenience store 7-Eleven, to force them to label their coffee with Prop. 65 warnings. The Los Angeles judge ruled that companies failed to demonstrate that the health benefits of coffee outweighed the risks posed by acrylamide, which include cancer and developmental and reproductive harm. 7-Eleven and some other companies have already settled out of court, agreeing to pay fines and place warning signs at the point of sale.

What does a Prop. 65 warning say and mean?

Up till now, generally words along the lines of: “WARNING: This product/area contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to”

Such signs on a product, or in a restaurant, workplace, living space or parking garage, mean that the product or environment contains a chemical on the Prop. 65 list. A business must give “clear and reasonable warning” if knowingly exposing anyone, unless it can show the exposure falls under “safe harbor” levels: amounts determined by the state to pose no significant risk. (California set acrylamide’s safe harbor levels for cancer risk at 0.2 micrograms per day — its estimation of a dose that would risk cancer developing in 1 in 100,000 people, based on laboratory rat data. It set the level for reproductive risk at 140 micrograms per day.)

Proposition 65 warnings, like this one at Disneyland, have generally been very vague. New laws will require that the warnings name specific chemicals and their sources. CREDIT: PATRICK PELLETIER / WIKIMEDIA COMMONS

Proposition 65 warnings, like this one at Disneyland, have generally been very vague. New laws will require that the warnings name specific chemicals and their sources. (Credit: Patrick Pelletier/Wikimedia Commons)

How does acrylamide end up in foods?

The chemical naturally forms in items such as baked goods, cereals, potato products and coffee during the Maillard, or browning, reaction, when the amino acid asparagine and a sugar combine in the presence of heat higher than 120 degrees Celsius (248°F).

“Any time you heat-process a food — toast a piece of bread, fry potatoes, bake a crust — sugars react with amino acids to form a whole catalog of chemicals. Acrylamide happens to be one of those chemicals,” says James Coughlin, a chemist in Aliso Viejo, California, and an independent consultant for the food industry. (Coughlin has consulted for the National Coffee Association and Starbucks in the past but is not currently working for any companies in the California court case.)

Acrylamide forms when bread is toasted and the amino acid asparagine reacts with sugars at high heat. CREDIT: MILOS LUZANIN / SHUTTERSTOCK

Acrylamide forms when bread is toasted and the amino acid asparagine reacts with sugars at high heat. (Credit: Milos Luzanin/Shutterstock)

When green coffee beans are roasted (typically at 180° to 240°C for about 15 minutes), more than 1,000 chemical compounds result as different sugars and amino acids combine and break down. “Coffee is the best example of the browning reaction gone wild,” Coughlin says. That swirl of chemicals gives coffee its complex tastes and aromas.

What is the evidence that acrylamide causes cancer or reproductive harm?

Acrylamide is used in industry and research to make polymers and is a neurotoxin at very high doses. It was found to be present in starchy, browned foods in 2002.

For cancer studies in 1986 and 1995, researchers fed rats high doses of acrylamide in their drinking water throughout their two-year lifetime. The highest doses increased rates of thyroid, testicular and breast tumors. In 2012, the US government’s National Toxicology Program (NTP), which tests environmental chemicals for potentially hazardous health effects, found similar increases in rats and mice. In male rats, the rate of thyroid tumors rose from 6 percent in rats fed no acrylamide to 25 percent in those fed the highest dose, for example. In females, the rate of a breast tumor rose from 33 percent without acrylamide to 65 percent for the highest dose.

(The NTP also assessed for reproductive harm in 2005 and found that while acrylamide causes slight increases in the incidence of low birth weight and less effective sperm in mice and rats fed high doses, there was no evidence that acrylamide exposure in people results in adverse reproductive effects.)

But experts say that the carcinogenicity of acrylamide in people is still up for debate. For one thing, says Coughlin, doses fed to rodents in these studies were extremely high — the equivalent of a 150-pound person drinking 11,000 to 136,500 eight-ounce cups of coffee per day. For another, population studies of workplace exposure to acrylamide have not found dose-related increases in any specific cancer or in overall cancer mortality.

An analysis of 25 epidemiology studies, encompassing 39,476 people, found no increased risk for 15 types of cancer when comparing people with average dietary intakes of acrylamide to those with daily intakes 10 micrograms higher (the amount in five eight-ounce cups of coffee). The authors concluded that dietary levels of acrylamide do not pose an increased risk of most types of cancer.

How do chemicals get on the Prop. 65 list?

In four ways. A chemical is automatically added if listed as a carcinogen or a developmental or reproductive toxicant by any of five authoritative bodies — the National Toxicology Program and three other US agencies, or the World Health Organization’s International Agency for Research on Cancer (IARC). It only takes one agency to spark a listing; in the case of acrylamide, all five agencies list it as a probable human carcinogen.

A chemical may also be added if the California Labor Code deems it a cancer or reproductive risk, or if another agency requires a label. And it can be added if California-appointed State Qualified Experts — committees of researchers who specialize in cancer or developmental and reproductive biology — review the science and declare a chemical harmful by a majority vote.

Processed meats such as sausages were listed in 2015 by the International Agency for Research on Cancer as “carcinogenic to humans,” based on population studies that reported slightly increased rates of colorectal cancer in people who consumed the meats. Some speculate that processed meats will soon be added to Proposition 65's list of chemicals. (Credit: Joshua Resnick/Shutterstock)

Processed meats such as sausages were listed in 2015 by the International Agency for Research on Cancer as “carcinogenic to humans,” based on population studies that reported slightly increased rates of colorectal cancer in people who consumed the meats. Some speculate that processed meats will soon be added to Proposition 65’s list of chemicals. (Credit: Joshua Resnick/Shutterstock)

That can be a tough call because the data are often imperfect, says toxicologist David Eastmond of the University of California, Riverside, a member of the Carcinogen Identification Committee. It bothers him that even if committees have reviewed a chemical and deemed it safe, another agency can override that work. “It’s not real often that you have differences,” he says. “But it makes you wonder, are you doing something consistent?”

Acrylamide was added to the Prop. 65 list in 1990 because both the IARC and the US Environmental Protection Agency (another of the triggering bodies) listed it as a carcinogen based on animal studies.

Are chemicals ever taken off the list?

Yes. Several have been delisted after studies showed them not to be carcinogens or reproductive toxins. (A reassessment can be triggered by State Qualified Experts, a state agency or petition by a member of the public.) One notable case is the artificial sweetener saccharin, which was listed as a carcinogen in 1989 because it caused bladder cancer in rodent studies, and was delisted in 2001. Decades of research showed that the way saccharin caused bladder cancer in male rats was not possible in humans.

Why are items listed when they might not be harmful to people?

The statute is designed to be precautionary and protective, says Claudia Polsky, director of the Environmental Law Clinic at UC Berkeley Law. “If it’s possible to decrease the levels of acrylamide in coffee, then people will have a lower exposure over their lifetime of a probable carcinogen,” she says. And the regulation, she adds, forces industry to innovate to find ways to remove or reduce harmful chemicals.

“Drinking coffee is still fine, and possibly even good for you,” she says. “But thanks to Prop. 65, coffee manufacturers might be able to make it even better.”

So is it safe to drink coffee or not?

The Food and Drug Administration, the European Food Safety Authority and Health Canada have all ruled coffee safe to drink, except for pregnant women, who should limit their intake.

A review of more than 100 epidemiology studies encompassing more than 21 million people found that coffee consumption has an overall health benefit, decreasing risks for a variety of diseases including cardiovascular disease, type II diabetes, Parkinson’s disease and several cancers.

Coughlin says that roasted coffee beans or their grounds contain about 450 micrograms of acrylamide per kilogram, but brewed coffee contains only about 10 to 30 — a tiny dose compared to eating french fries or potato chips, which can contain acrylamide in the thousands of micrograms. The amount in an eight-ounce cup of coffee, 2 micrograms, is ten times the state’s safe harbor level of 0.2 micrograms a day. Acrylamide reacts with other proteins in the body as soon as it is absorbed, Coughlin adds, and is also detoxified by an enzyme called glutathione transferase.

Saccharin, found in products such as Sweet'N Low, was removed from Proposition 65’s list of risky chemicals in 2001. Decades of research showed it did not pose a cancer risk in people. (Credit: elbud/Shutterstock)

Saccharin, found in products such as Sweet’N Low, was removed from Proposition 65’s list of risky chemicals in 2001. Decades of research showed it did not pose a cancer risk in people. (Credit: elbud/Shutterstock)

“The bottom line for coffee is that while it does contain a small dose of acrylamide along with several other animal carcinogens, the overall beverage is loaded with antioxidants and has been shown to reduce the risk of several cancers,” he says.

Could it be made safer?

Maybe. After potato chip and french fry makers were sued by the California attorney general in 2005, they found ways to reduce acrylamide levels. Potatoes can be blanched to reduce sugar content, treated with an enzyme to remove much of the asparagine, or cooked for less time or at lower temperatures.

But coffee is trickier. Coffee company scientists say they have tried to reduce acrylamide levels by altering roasting times or steaming, but achieved only modest reductions and distorted the brew’s flavor and aroma.

Does Prop. 65 do a good job of protecting people from harmful chemicals?

Polsky and others who support the law point to Prop. 65’s successes: Coke and Pepsi removed 4-methylimidazole, a carcinogen in caramel coloring, from their sodas; companies have removed lead, a potent developmental toxin, from children’s jewelry, wine bottle caps and candy imported to the United States from Mexico. Target and CVS pharmacies have pledged to remove phthalates and formaldehyde from cosmetics and personal-care products due in part to pressure from the law.

But some worry that the sheer number of Prop. 65 warning signs seen in parking garages, auto mechanic shops, dentist’s and doctor’s offices and coffee shops erodes their clout. “Are you unduly frightening the public or are you posting warnings so often that people ignore them?” asks Eastmond. “Coffee and acrylamide might be one of those cases where we are warning someone about something that’s not really a serious health concern.”

Megan Schwarzman, an environmental health scientist and physician at the UC Berkeley School of Public Health, agrees that the media spotlight on what looks like an absurd coffee warning could undermine the law’s effectiveness and overshadow cases where it has compelled large companies to remove or reduce truly dangerous chemicals.

And Schwarzman, Coughlin and Eastmond all point to one major failing of the law: It does not take into account the doses that were used in toxicology studies when deciding to list a chemical. People drinking coffee — even large amounts daily — do not come remotely close to the concentrations that caused harm in animal tests.

There hasn’t been a scientific evaluation of the law’s effectiveness to date. But Schwarzman, Polsky and a team of researchers are taking the first systematic look at whether Proposition 65 has been effective in one particular arena: reducing exposure of Californians to chemicals associated with breast cancer, such as endocrine disruptors, phthalate plasticizers and diesel exhaust.

Could Prop. 65 be improved?

Experts agree that there’s room for improvement in the way the statute is written and enforced.

One major criticism is that Prop. 65 warnings are too generic to be useful. Until now, signs usually have not noted which chemicals are present or whether people are at risk from, say, just walking to and from a parked car in a garage. Nor do they distinguish between high, medium and low risks. Warnings, Schwarzman says, should “only exist for significant public health risks.”

New rules taking effect in August will require inclusion of names of specific chemicals and their source.

Another criticism is that the law has become a cash cow for law firms seeking to force companies into settlements. In 2015, $26 million was paid in Prop. 65 settlements, of which nearly $18 million, or 68 percent, went toward plaintiff attorney fees. In 2016, the California attorney general’s office, which enforces Prop. 65, changed how settlements could be made in Prop. 65 lawsuits brought by private plaintiffs. The aim was to limit the portion of settlements that could go to plaintiffs and ensure that the state got its fair share of civil penalties. There still is no limit on how much of a settlement can go toward paying plaintiff attorney fees.

In another ongoing Prop. 65 court case, a judge ruled that the herbicide chemical glyphosate did not have to be labeled. Why not?

Glyphosate is a chemical found in the widely popular herbicide Roundup, produced by the company Monsanto.

Of the five triggering agencies, only the World Health Organization’s IARC has classified the chemical as a “probable human carcinogen.” The other four say it has low toxicity and does not pose a risk. Glyphosate went on the Prop. 65 list in July 2017.

The IARC is the most precautionary of the five triggering agencies, and works only with published data. In situations where much of the research is proprietary, that can be an issue, Eastmond says. He says he has seen the extensive unpublished data on glyphosate toxicology in rats, and epidemiology in exposed farm workers, and believes that the IARC very likely would not have reached the conclusion it did if it had reviewed those data too.

Monsanto does not want glyphosate regulated under Prop. 65 and sued the state of California in federal court in November 2017 to prevent a labeling requirement. A judge ruled in February that since only one agency had found glyphosate a possible carcinogen, the company could not be compelled to label its product as “known to cause cancer”; that would be compelled speech and could mislead a reasonable consumer. Glyphosate remains on the Prop. 65 list, but the judge temporarily barred the state from enforcing the warning requirement.

Neither the coffee nor the glyphosate case is settled. Some of the coffee companies may appeal after the final judgment of the penalty phase of that case is decided this summer or later, and the glyphosate ruling is just a “preliminary injunction” as that case proceeds.

What lawsuits might come next?

Prop. 65 lawsuits are scattershot and hard to predict, but there are clues. In the first week of May alone, private citizens filed 29 notices of violation with the California attorney general’s office seeking to sue companies for Prop. 65 violations. The complaints target items like phthalates in cosmetics, acrylamide in almonds and lead in dietary supplements. The notified companies include CVS pharmacies, Trader Joe’s and Nordstrom.

What might be listed next?

Processed meats — such as bacon and hot dogs — were listed in 2015 by the IARC as “carcinogenic to humans.” The agency listed red meat as “probably carcinogenic to humans” (the same category as acrylamide) because the evidence was more limited. Both listings, finalized in March, were based on epidemiological studies of colorectal cancer, which showed slightly increased risks associated with processed meat and red-meat consumption.

Coughlin suspects that this will trigger California to add processed meats to the Prop. 65 list. Interestingly, after facing public uproar in 2015, the WHO released a statement that processed meats were still part of a healthy diet.

This article originally appeared in Knowable Magazine, an independent journalistic endeavor from Annual Reviews. Sign up for the newsletter.

Knowable Magazine | Annual Reviews

Continue Reading


New Detector Brings X-ray Scans Into Living Color For the First Time

A 3D image of a wrist with a watch showing part of the finger bones in white and soft tissue in red. (Image: MARS Bioimaging Ltd)

Like Dorothy coming to Oz, doctors might finally be experiencing their world in color.

A new scanner, using technology developed by CERN for detecting subatomic particles, can produce color X-ray scans of the inside of the body, allowing doctors to see soft tissues in unprecedented detail. The technology is set for clinical trials in New Zealand soon.

X-ray Upgrade

Normal X-rays illuminate our insides in shades of grey — hard tissues like bone are white and soft tissues are black. That’s because normal detectors only read whether the x-rays are coming through or not. Bone blocks X-rays, so they show up as white; soft tissues don’t, so they’re black.

The new detector was made by New Zealand-based company Medipix. Their tech is based on detectors used by the Large Hadron Collider for measuring particles created by protons smashing together at nearly the speed of light. And it can pick out subtle changes in the energy levels of the incoming X-rays to tell a more detailed story about the types of tissues it passes through. Muscle, fat, connective tissues and more all alter the x-rays in different ways, and the new detector picks up on that.


Paired with algorithms specialized for putting this information together and spitting it back out as cohesive images, doctors can now see a 3-dimensional view of the body where each type of tissue stands out distinctly. The colors themselves aren’t necessarily “true” color — they’re added in afterwards to distinguish various tissue types — but they do give doctors much more information from a standard x-ray scan than before. The technology could conceivably be used to search for tumors, assess bone and joint health and provide updates on vascular health, among other things.

That’s pending clinical safety trials, of course, but the technology does offer essentially an upgrade to an existing technique, which might help smooth the process along. It’s a positive for doctors, though for the rest of us who might not enjoy seeing the insides of our bodies in high-resolution, well, we might just have to look away.

Continue Reading


@RuggieriJoe @gblondon1 I stopped using apps about 6 weeks ago Joe (never used gett). Been doing plenty,and I keep all the fare and tips. #parasites

Intestinal parasite cases spiking in Illinois also hitting Rock River Valley ⁦@IDPH⁩ ⁦@WinnCountyNews#parasites…


A combination regimen comprised of #azithromycin & #ivermectin is associated w/ similar reductions in #scabies & #impetigo compared w/ #ivermectin monotherapy in communities w/ high rates of these infections

test Twitter Media - A combination regimen comprised of #azithromycin & #ivermectin is associated w/ similar reductions in #scabies & #impetigo compared w/ #ivermectin monotherapy in communities w/ high rates of these infections

Adding #azithromycin to #ivermectin does not improve impetigo, scabies treatment

Treatment with #azithromycin plus #ivermectin versus ivermectin alone provides equal protection against #scabies & #impetigo in at-risk communities, new @LSHTM study finds

test Twitter Media - Treatment with #azithromycin plus #ivermectin versus ivermectin alone provides equal protection against #scabies & #impetigo in at-risk communities, new @LSHTM study finds